Loading clinical trials...
Loading clinical trials...
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Conditions
Interventions
GSK249320 100/mg
Placebo
Locations
36
United States
GSK Investigational Site
Orange, California, United States
GSK Investigational Site
Jacksonville, Florida, United States
GSK Investigational Site
Peoria, Illinois, United States
GSK Investigational Site
Lexington, Kentucky, United States
GSK Investigational Site
Portland, Oregon, United States
GSK Investigational Site
Nashville, Tennessee, United States
Start Date
May 18, 2013
Primary Completion Date
July 28, 2014
Completion Date
July 28, 2014
Last Updated
November 17, 2017
NCT06241677
NCT05651945
NCT07272239
NCT07113067
NCT06253000
NCT00084292
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions